Cross-Sector Q2 2026 Earnings: Semiconductor and Energy Providers Beat EstimatesGlobal Report·Aug 11 at 05:13 AMPBF-3.02%EXFY+3.60%
GenFleet doses first patient in China Phase III trial of KRAS G12D inhibitor GFH375 for NSCLCPUBT·Aug 9 at 07:01 PM02595-1.85%
Verastem (NASDAQ:VSTM) Posts Earnings Results, Beats Estimates By $0.08 EPSMarket Beat·Aug 7 at 05:26 PMVSTM-1.35%
Verastem | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 40.08 MEarnings Watch·Aug 6 at 05:10 PMVSTM-1.35%
Verastem Q2 FY26 GAAP net loss widens to $34.67 million; revenue rises to $40.08 millionPUBT·Aug 6 at 03:06 PMVSTM-1.35%
AI Infrastructure Spend Fuels Amkor and Viavi, But Logitech Warns of Supply ShocksGlobal Report·Aug 4 at 04:17 AMLOGI-1.38%VIAV+1.28%
Verastem Oncology to report Q2 2026 financial results in conference callPUBT·Jul 23 at 06:30 AMVSTM-1.35%
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Whybenzinga_article·Jul 21 at 02:52 PMRGNX+0.98%ADCT-3.81%
The Heterogeneity of Value Chains: From Synthetic Biology to Cloud AggregatorsGlobal Report·Jul 14 at 06:47 AMDDOG+1.28%TWST-5.36%
Under the Radar: The Tech, Biotech, and Defense Shifts You MissedGlobal Report·Jul 8 at 10:32 PMVSTM-1.35%TBI+0.89%
